Parkinson's Disease Trial, Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- You are scheduled to have a new brain stimulation device implanted, or have an existing device's battery replaced, using an Abbott deep brain stimulation system, within the next 180 days.
- You (or a legal representative on your behalf) are willing and able to sign a written consent form before any study activities begin.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- You are currently taking part in, or planning to join, another research study that could affect the results of this trial.
- You have physical health conditions, other medical issues, or social or psychological circumstances that, in the doctor's opinion, might make it difficult for you to fully participate or attend follow-up appointments (confirm with trial site).
- If the trial site is in the United States, your reason for receiving the brain stimulation device is something other than Parkinson's disease or severe, disabling tremor.
- If the trial site is in the United States, the planned location in the brain where the device leads will be placed is not in one of three specific target areas used for Parkinson's disease or tremor treatment (confirm with trial site).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
2 site(s) in Australia. Confirm current status and contact details directly with the trial site.
Primary endpoints
Change from baseline to 6 months in disease-specific motor rating scale. For subjects with Parkinson's disease, MDS-UPDRS Part III.; Change from baseline to1 year in disease-specific motor rating scale. For subjects with Parkinson's disease, MDS-UPDRS Part III.; Change from baseline to 2 years in disease-specific motor rating scale. For subjects with Parkinson's disease, MDS-UPDRS Part III.; Change from baseline to 3 years in disease-specific motor rating scale. For subjects with Parkinson's disease, MDS-UPDRS Part III.; Change from baseline to 4 years in disease-specific motor rating scale. F...
Can't join this trial?
Data last synced from ClinicalTrials.gov: 1 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.